Here, our in silico analysis showed the miR-17 ̃92 cluster and its paralogs to be elevated in PN GBM, potentially indicating an enhanced role for the E2F cell cycle pathway and potential sensitivity to a CDK4/6 inhibitor in PN GBM. Here, CDK4 is linked to glioblastoma.